Anúncio
Anúncio
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
105.00
USDPatrocinado
-2.05
-1.91%
02 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
110.00
+5.00
+4.77%
Relatórios de Lucros RYTM
Rácio de surpresa positiva
RYTM separação 17 de 33 últimas estimativas.
52%
Próximo Relatório
Data do Próximo Relatório
24 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$56.12M
/-$0.83
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+9.40%
/+1.22%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+34.16%
/+15.28%
Rhythm Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On 04 de nov. de 2025, RYTM reported earnings of -0.82 USD per share (EPS) for Q3 25, missing the estimate of -0.73 USD, resulting in a -11.05% surprise. Revenue reached 51.30 milhão, compared to an expected 51.72 milhão, with a -0.81% difference. The market reacted with a -7.69% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 17 analistas forecast an EPS of -0.83 USD, with revenue projected to reach 56.12 milhão USD, implying an aumentar of 1.22% EPS, and aumentar of 9.40% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
22 de dez. de 2025 Para Q4 25
Estimativa
-$0.57
Real
-$0.73
Surpresa
-25.95%
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
What were Rhythm Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Rhythm Pharmaceuticals, Inc. Common Stock reported EPS of -$0.82, missing estimates by -11.05%, and revenue of $51.30M, -0.81% below expectations.
How did the market react to Rhythm Pharmaceuticals, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -7.69%, changed from $113.74 before the earnings release to $104.99 the day after.
When is Rhythm Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for 24 de fev. de 2026.
What are the forecasts for Rhythm Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 17
analistas, Rhythm Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.83 and revenue of $56.12M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio